This bill creates the "Lab Services Accessibility Act," which modifies New York's public health law to expand exemptions for clinical laboratories providing specific public health services. It directly affects clinical laboratories and health service providers operating under public health programs, such as pregnancy testing, sexually transmitted infection screening, pandemic response, and care for underserved populations. Key provisions (Section 3) add new payment exemptions, allowing services for these programs to be covered without triggering certain regulatory requirements - specifically, by entities like hospitals, insurers, or public health initiatives. The law aims to streamline access to essential lab services by clarifying payment pathways for priority health needs.
This bill allows medical assistants in outpatient clinics to draw and administer vaccines under direct supervision by a physician, nurse practitioner, or physician assistant. It specifically permits this for vaccines recommended by federal health authorities (like the CDC), requiring medical assistants to complete required training and receive adequate oversight. The law directly affects medical assistants, clinics, and healthcare providers who administer routine vaccines, expanding their scope of practice for vaccination tasks. Key provisions include mandatory federal vaccine recommendations, required training, and supervision requirements to ensure patient safety. The bill does not change vaccine types or eligibility but modifies who can legally administer them in office settings.
This bill (S 707) requires managed long term care plans in New York to include specific data in annual reports to the state Department of Health, replacing previous biannual reporting. It mandates detailed metrics on service utilization (like hours of personal care), expenditures (broken down by service type), complaint resolution rates, timely access to care, and rebalancing efforts shifting care from nursing homes to home-based settings. These reports must be published annually on the Department’s website in an interactive format for public comparison, covering statewide and regional data. The changes directly affect managed care plans (which provide long-term care services), the Department of Health (which collects and publishes the data), and enrollees (whose care quality and access are measured).
Bill S 3689 amends the real property actions and proceedings law to protect tenants using medical marihuana. It prohibits landlords from evicting a tenant from a residential unit solely because of their certified medical use of medical marihuana. The bill establishes this as a defense for tenants in eviction proceedings. However, it also clarifies that landlords retain their legal rights to recover possession for any other lawful grounds not related to medical marihuana use.
Requires the administration of certain vaccines for children in accordance with regulations issued by the commissioner, utilizing generally accepted medical standards and based on recommendations of the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Physicians, the Advisory Committee on Immunization Practices, or other similar nationally or internationally recognized scientific organizations.
Relates to the establishment of regulations for administering immunizations taking into consideration the recommendations of the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Physicians, the advisory committee on immunization practices, any interstate body established for purposes of reviewing and making recommendations regarding immunization coverage and access, or other similar nationally or internationally recognized scientific organizations.
S 8334 requires health insurance plans to cover all recommended doses of the COVID-19 vaccine (SARS-CoV-2), adding it to a list of mandatory immunizations already covered by New York insurance law. This affects insurance companies, healthcare providers, and patients by mandating reimbursement for the vaccine without cost-sharing. The bill amends multiple sections of New York’s insurance and social services laws to include "severe acute respiratory syndrome coronavirus 2" in required coverage, aligning with federal standards for biological products. It applies to all insurance contracts effective January 1 after the law takes effect.
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
Relates to requirements for medical professionals and health care facilities that provide medication to patients for medical aid in dying; extends the initial effectiveness of certain provisions relating thereto.